249 related articles for article (PubMed ID: 33818715)
21. Obesity and Metabolic Unhealthiness Have Different Effects on Colorectal Neoplasms.
Ko SH; Baeg MK; Ko SY; Jung HS; Kim P; Choi MG
J Clin Endocrinol Metab; 2017 Aug; 102(8):2762-2769. PubMed ID: 28510711
[TBL] [Abstract][Full Text] [Related]
22. Association of metabolically unhealthy non-obese and metabolically healthy obese individuals with arterial stiffness and 10-year cardiovascular disease risk: a cross-sectional study in Chinese adults.
Guo W; Jia J; Zhan M; Li X; Zhu W; Lu J; Zhao X; Xu N; Zhang Q
Nutr J; 2023 Sep; 22(1):44. PubMed ID: 37726745
[TBL] [Abstract][Full Text] [Related]
23. Influence of Obesity and Metabolic Abnormalities on the Risk of Developing Colorectal Neoplasia.
Kim NH; Jung YS; Park JH; Park DI; Sohn CI
Dig Dis Sci; 2018 Nov; 63(11):3126-3133. PubMed ID: 30094620
[TBL] [Abstract][Full Text] [Related]
24. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.
Jam SA; Moloudpour B; Najafi F; Darbandi M; Pasdar Y
BMC Nephrol; 2022 Jul; 23(1):233. PubMed ID: 35778682
[TBL] [Abstract][Full Text] [Related]
25. Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study.
Kim HS; Lee J; Cho YK; Park JY; Lee WJ; Kim YJ; Jung CH
Front Endocrinol (Lausanne); 2021; 12():625083. PubMed ID: 33716978
[TBL] [Abstract][Full Text] [Related]
26. Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
Lee H; Choi EK; Lee SH; Han KD; Rhee TM; Park CS; Lee SR; Choe WS; Lim WH; Kang SH; Cha MJ; Oh S
Int J Cardiol; 2017 Aug; 240():221-227. PubMed ID: 28385358
[TBL] [Abstract][Full Text] [Related]
27. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.
Oh CM; Park JH; Chung HS; Yu JM; Chung W; Kang JG; Moon S
Medicine (Baltimore); 2020 Sep; 99(38):e22036. PubMed ID: 32957321
[TBL] [Abstract][Full Text] [Related]
28. Impact of obesity and metabolic abnormalities on the risk of metachronous colorectal neoplasia after polypectomy in men.
Kim NH; Jung YS; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2019 Sep; 34(9):1504-1510. PubMed ID: 31062426
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
[No Abstract] [Full Text] [Related]
30. Characteristics of Serum Thyroid Hormones in Different Metabolic Phenotypes of Obesity.
Nie X; Ma X; Xu Y; Shen Y; Wang Y; Bao Y
Front Endocrinol (Lausanne); 2020; 11():68. PubMed ID: 32184757
[No Abstract] [Full Text] [Related]
31. Natural History of Obesity Subphenotypes: Dynamic Changes Over Two Decades and Prognosis in the Framingham Heart Study.
Echouffo-Tcheugui JB; Short MI; Xanthakis V; Field P; Sponholtz TR; Larson MG; Vasan RS
J Clin Endocrinol Metab; 2019 Mar; 104(3):738-752. PubMed ID: 30339231
[TBL] [Abstract][Full Text] [Related]
32. Association between Metabolic Obesity Phenotypes and the Burden of Hospitalized Postmenopausal Patients Concomitant with Osteoporosis: A Retrospective Cohort Study Based on the National Readmission Database.
Jiang J; Xu C; Yuan Z; Han J; Wang Z; Tian Y; Dong Y; Xia W; Fan X; Zhao J
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836159
[TBL] [Abstract][Full Text] [Related]
33. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
Fingeret M; Marques-Vidal P; Vollenweider P
Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
[TBL] [Abstract][Full Text] [Related]
34. Visceral Adiposity, Pro-Inflammatory Signaling and Vasculopathy in Metabolically Unhealthy Non-Obesity Phenotype.
Tsou MT; Yun CH; Lin JL; Sung KT; Tsai JP; Huang WH; Liu CY; Hou CJ; Tsai IH; Su CH; Hung CL; Hung TC
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33383705
[TBL] [Abstract][Full Text] [Related]
35. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.
Wang Y; Sun B; Sheng LT; Pan XF; Zhou Y; Zhu J; Li X; Yang K; Guo K; Zhang X; He M; Yang H; Wu T; Pan A
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2017-2026. PubMed ID: 32826134
[TBL] [Abstract][Full Text] [Related]
36. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
[TBL] [Abstract][Full Text] [Related]
37. Associations between residential greenness and obesity phenotypes among adults in Southwest China.
Yu B; Tang W; Fan Y; Ma C; Ye T; Cai C; Xie Y; Shi Y; Baima K; Yang T; Wang Y; Jia P; Yang S
Health Place; 2024 May; 87():103236. PubMed ID: 38593578
[TBL] [Abstract][Full Text] [Related]
38. All-cause mortality risk with different metabolic abdominal obesity phenotypes: the Rural Chinese Cohort Study.
Wu X; Zhao Y; Zhou Q; Han M; Qie R; Qin P; Zhang Y; Huang Z; Liu J; Hu F; Luo X; Zhang M; Liu Y; Sun X; Hu D
Br J Nutr; 2023 Nov; 130(9):1637-1644. PubMed ID: 36924137
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Phenotypes-The Game Changer in Quality of Life of Obese Patients?
Mitu I; Preda C; Dimitriu CD; Mitu O; Costache II; Ciocoiu M
Healthcare (Basel); 2022 Mar; 10(4):. PubMed ID: 35455798
[TBL] [Abstract][Full Text] [Related]
40. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
